Discovery in Our Labs
The Winthrop P. Rockefeller Cancer Institute directs cancer research for the University of Arkansas for Medical Sciences (UAMS) and its affiliated institutions. Cancer Institute scientists are committed to reducing cancer incidence, mortality and morbidity in Arkansas and the surrounding region.
The Cancer Institute accomplishes its goals through focused research programs, shared resources and multidisciplinary disease-specific committees.
The Cancer Institute’s approach is simple: Discovery in our labs leads to the development of new treatment strategies, which are then delivered to the patients in our clinics. The bottom line for our patients is that our research fuels innovative treatment options.
Why I Do Cancer Research.
First, you need to know how biology works when in good health, before you can understand what is different in a disease and, then, how to treat it.
Read MoreOur Research
Research Programs
All research at the Cancer Institute is organized into four distinct research programs to maximize and nurture scientific collaborations and productivity.
Learn More
Shared Resources
Shared resources provide Cancer Institute members with cost-effective access to specialized technologies, methodologies and quality control.
Learn More
Internal Funding
Internal funds available to support cancer research are updated monthly.
Learn More
Membership
Membership in the Winthrop P. Rockefeller Cancer Institute is available through application to any faculty member who is engaged in cancer research.
Learn MoreResearch: UAMS Establishes Proteomics Center of Excellence in Little Rock with Thermo Fisher Scientific
The University of Arkansas for Medical Sciences (UAMS) announced the launch of the Thermo Fisher Scientific Center of Excellence for Proteomics at UAMS — the first and only academic-industry partnership of its kind in the United States. The world leader in serving science, Thermo Fisher Scientific, entered into a formal agreement with the IDeA National…
More News
Symposium Showcases Promising Research Aimed at Reducing Cancer Therapy Side Effects
What is worse? Cancer or cancer treatment? Ask any patient treated with chemotherapy, and the answer may be the treatment. Common side effects of chemotherapy include pain, fatigue, hair loss, mouth sores, bowel issues as well as nerve, muscle, cell and organ damage. And that’s just chemotherapy. Conventional X-ray radiation, a treatment needed by half…
Read more
Marius Nagalo, Ph.D., First at UAMS to Receive NIH New Innovator Award
LITTLE ROCK — A researcher at the Winthrop P Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), Marius Nagalo, Ph.D., has received the prestigious New Innovator Award from the National Institutes of Health (NIH).
Read more
UAMS’ Michael Birrer, M.D., Ph.D., Publishes Study Results in JAMA Oncology on Treatment for Incurable Cervical Cancer
The results of an international clinical trial led by Michael Birrer, M.D., Ph.D., director of the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), on the use of a novel bispecific antibody for women with recurrent or metastatic cervical cancer were published today in JAMA Oncology. Cervical cancer is…
Read more
UAMS Winthrop P. Rockefeller Cancer Institute Awarded Five New Grants from National Cancer Institute
Researchers at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) have been awarded five new grants from the National Cancer Institute (NCI) in 2024, totaling $4.6 million. New grants include: $3.3 million NCI grant to create a Melanoma Resistance Evolution Atlas, Principal Investigator: Alan Tackett, Ph.D., Winthrop P….
Read moreWant to read more stories like these?